MBS146255 | Recombinant Human Serine Peptidase Inhibitor Kazal Type 7 

(No reviews yet) Write a Review
SKU:
MBS146255
Availability:
Usually Shipped in 5 Working Days
zł2,024.00 - zł58,568.00
Frequently bought together:

Description

Recombinant Human Serine Peptidase Inhibitor Kazal Type 7  | MBS146255 | MyBiosource

Product Short Name: [Serine Peptidase Inhibitor Kazal Type 7 ]

Product Name Synonyme: [SPINK7 Human; Serine Peptidase Inhibitor Kazal Type 7 Human Recombinant; Serine peptidase inhibitor Kazal type 7; ECG2; ECRG2; Serine protease inhibitor Kazal-type 7; Esophagus cancer-related gene 2 protein; ECRG-2; SPINK7]

Other Names: [serine protease inhibitor Kazal-type 7; Serine protease inhibitor Kazal-type 7; serine protease inhibitor Kazal-type 7; ECRG-2; esophagus cancer related gene 2; esophagus cancer-related gene 2 protein; esophagus cancer-related gene-2; serine peptidase inhibitor, Kazal type 7 (putative); Esophagus cancer-related gene 2 protein; ECRG-2]

Product Gene Name: [SPINK7]

Product Gene Name Synonyme: N/A

Other Gene Names: [SPINK7; SPINK7; ECG2; ECRG2; ECG2; ECRG-2]

Clonality: N/A

Isotype: N/A

Clone: N/A

Host: E Coli

Reactivity: N/A

Specificity: N/A

Purity: Greater than 85.0% as determined by SDS-PAGE.

Form: The SPINK7 solution (0.25mg/ml) contains 20mM Tris-HCl buffer (pH 8.0), 0.2M NaCl, 40% glycerol and 2mM DTT.
Sterile Filtered colorless solution.

Concentration: N/A

Storage Stability: Store at 4 degree C if entire vial will be used within 2-4 weeks. Store, frozen at -20 degree C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles.

Tested Application: N/A

View AllClose